Literature DB >> 23045431

Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.

Manoch Rattanasompattikul1, Miklos Z Molnar, Joshua J Zaritsky, Parta Hatamizadeh, Jennie Jing, Keith C Norris, Csaba P Kovesdy, Kamyar Kalantar-Zadeh.   

Abstract

BACKGROUND: Protein-energy wasting, inflammation and refractory anemia are common in long-term hemodialysis patients. A decreased responsiveness to erythropoiesis-stimulating agents (ESA) is often the cause of the refractory anemia. We hypothesized that the malnutrition-inflammation complex is an independent predictor of decreased responsiveness to ESAs in hemodialysis patients.
METHODS: This cohort study of 754 hemodialysis patients was examined for an association between inflammatory and nutritional markers, including the malnutrition-inflammation score (MIS) and responsiveness to ESA. Cubic spline models were fitted to verify found associations.
RESULTS: The mean (±SD) age of patients was 54 ± 15 years, 53% were diabetic and 32% blacks. MIS was worse in the highest quartile of ESAs responsiveness index (ERI, ESA dose divided by hemoglobin) when compared with 1st quartile (6.5 ± 4.5 versus 4.4 ± 3.4; P < 0.001). Both C-reactive protein (log CRP) (β = 0.19) and interleukin-6 (log IL-6) (β = 0.32) were strong and independent predictors of ERI using multivariate linear regression. Serum albumin (β = -0.30) and prealbumin levels (β = -0.14) were inversely associated with ERI. Each 1 SD higher MIS, higher CRP and lower albumin were associated with 86, 44 and 97% higher likelihood of having highest versus three lowest ERI quartiles in fully adjusted models [odds ratio (and 95% confidence interval) of 1.86 (1.31-2.85), 1.44 (1.08-1.92) and 1.97 (1.41-2.78)], respectively. Cubic splines confirmed the continuous and incremental nature of these associations.
CONCLUSIONS: Malnutrition-inflammation complex is an incremental predictor of poor responsiveness to ESAs in hemodialysis patients. Further studies are needed to assess whether modulating inflammatory or nutritional processes can improve anemia management.

Entities:  

Keywords:  erythropoietin-stimulating agent (ESA) therapy; hemoglobin; inflammatory marker; malnutrition–inflammation complex; responsiveness to ESAs

Mesh:

Substances:

Year:  2012        PMID: 23045431      PMCID: PMC3707522          DOI: 10.1093/ndt/gfs368

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  65 in total

1.  Ultrapure dialysate reduces dose of recombinant human erythropoietin.

Authors:  H Schiffl; S M Lang; A Bergner
Journal:  Nephron       Date:  1999       Impact factor: 2.847

Review 2.  Genomics of cardiovascular disease.

Authors:  Christopher J O'Donnell; Elizabeth G Nabel
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

3.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

4.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors:  Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

Review 5.  Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.

Authors:  Brian D Bradbury; M Alan Brookhart; Wolfgang C Winkelmayer; Cathy W Critchlow; Ryan D Kilpatrick; Marshall M Joffe; Harold I Feldman; John F Acquavella; Ouhong Wang; Kenneth J Rothman
Journal:  Am J Kidney Dis       Date:  2009-07-09       Impact factor: 8.860

6.  Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey.

Authors:  V Panichi; M Migliori; S De Pietro; M R Metelli; D Taccola; R Perez; R Palla; P Rindi; R Cristofani; C Tetta
Journal:  Blood Purif       Date:  2000       Impact factor: 2.614

7.  Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.

Authors:  Jérôme Rossert; Cristiana Gassmann-Mayer; Dieter Frei; William McClellan
Journal:  Nephrol Dial Transplant       Date:  2007-01-08       Impact factor: 5.992

Review 8.  Pathophysiology of anemia and erythrocytosis.

Authors:  Vivien M Hodges; Susan Rainey; Terence R Lappin; A Peter Maxwell
Journal:  Crit Rev Oncol Hematol       Date:  2007-07-25       Impact factor: 6.312

9.  Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.

Authors:  Mingxin Wei; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2007-05-30       Impact factor: 2.370

10.  Nutritional status and immune functions in maintenance hemodialysis patients.

Authors:  Hayriye Sayarlioglu; Reha Erkoc; Cengiz Demir; Ekrem Dogan; Mehmet Sayarlioglu; Ahmet Faik Oner; Imdat Dilek
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

View more
  33 in total

1.  Nutritional status in short daily hemodialysis versus conventional hemodialysis patients in China.

Authors:  Jielong Jiang; Lijun Ni; Wei Ren; Xiaowan Zhou; Keliang Su; Lihua Wang; Lei Lan; Wei Chen; Yuanbo Wu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

2.  A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.

Authors:  Holly M Koncicki; Steven Fishbane
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

Review 3.  Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.

Authors:  Keith C Norris; Sandra F Williams; Connie M Rhee; Susanne B Nicholas; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; L Ebony Boulware
Journal:  Semin Dial       Date:  2017-03-09       Impact factor: 3.455

Review 4.  Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.

Authors:  Bradley A Warady; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

5.  The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Luciana Tanca; Maria Cristina Cherchi; Carlo Floris; Itaru Omoto; Antonio Barracca; Tomas Ganz
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

6.  A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.

Authors:  Behzad Heidari; Muhammad Reza Fazli; Muhammad Ali Ghazi Misaeid; Parham Heidari; Niloofar Hakimi; Abbas Ali Zeraati
Journal:  Clin Exp Nephrol       Date:  2014-11-08       Impact factor: 2.801

7.  Revisiting the association between altitude and mortality in dialysis patients.

Authors:  Bryan B Shapiro; Elani Streja; Connie M Rhee; Miklos Z Molnar; Leeka Kheifets; Csaba P Kovesdy; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Hemodial Int       Date:  2014-01-15       Impact factor: 1.812

8.  Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study.

Authors:  Rieko Eriguchi; Masatomo Taniguchi; Toshiharu Ninomiya; Hideki Hirakata; Satoru Fujimi; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  J Nephrol       Date:  2014-07-31       Impact factor: 3.902

9.  The Prognostic Value of High-sensitivity C-reactive Protein and Prealbumin for Short-term Mortality in Acutely Hospitalized Multimorbid Elderly Patients: A Prospective Cohort Study.

Authors:  A Nouvenne; A Ticinesi; F Lauretani; M Maggio; G Lippi; B Prati; L Borghi; T Meschi
Journal:  J Nutr Health Aging       Date:  2016-04       Impact factor: 4.075

10.  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Authors:  Teppei Okamoto; Shingo Hatakeyama; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Takuya Koie; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.